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Accepted 28 February 2008Background: Good recruitment is integral to the conduct of a high-quality randomised
controlled trial. It has been suggested that recruitment is particularly difﬁcult for evaluations of
surgical interventions, a ﬁeld in which there is a dearth of evidence from randomised
comparisons. While there is anecdotal speculation to support the inference that recruitment to
surgical trials is more challenging than for medical trials we are unaware of any formal
assessment of this. In this paper, we compare recruitment to surgical and medical trials using a
cohort of publicly funded trials.
Data: Overall recruitment to trials was assessed using of a cohort of publicly funded trials
(n=114). Comparisons were made by using the Recruitment Index, a simple measure of
recruitment activity for multicentre randomised controlled trials. Recruitment at the centre
level was also investigated through three example surgical trials.
Results: The Recruitment Index was found to be higher, though not statistically signiﬁcantly, in
the surgical group (n=18, median=38.0 IQR (10.7, 77.4)) versus (n=81, median=34.8 IQR (11.7,
98.0)) days per recruit for the medical group (median difference 1.7 (−19.2, 25.1); p=0.828). For
the trials where the comparison was between a surgical and a medical intervention, the
Recruitment Index was substantially higher (n=6, 68.3 (23.5, 294.8)) versus (n=93, 34.6 (11.7,
90.0); median difference 25.9 (−35.5, 221.8); p=0.291) for the other trials.
Conclusions: There was no clear evidence that surgical trials differ frommedical trials in terms
of recruitment activity. There was, however, support for the inference that medical versus
surgical trials are more difﬁcult to recruit to. Formal exploration of the recruitment data
through a modelling approach may go some way to tease out where important differences
exist.
© 2008 Elsevier Inc. Open access under CC BY license.Keywords:
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Good recruitment is integral to the conduct of a high-
quality randomised controlled trial. However, many trials
struggle to recruit to their original target in terms of bothh Unit, University of
rdeen, AB25 2ZD, UK.
Y license.time and budget [1–3]. It has been suggested that recruit-
ment is particularly difﬁcult for evaluations of surgical
interventions, a ﬁeld in which there is a dearth of evidence
from randomised comparisons [4–6]. Strong preferences
amongst surgeons and potential participants, as well as
limitations on resources both infrastructure (theatre time)
and staff availability (surgical team), have been highlighted
as possible explanations.
A surgical trial can be deﬁned as a trial undertaking a
randomised comparison of a surgical procedure against some
form of control. Various options are available for the control,
Table 1
Summary recruitment information on the cohort of multicentre trials
Trial feature — median (IQR) Surgical trials Medical trials
N=18 N=81
Number of centres 12 (4, 28) 16 (5, 49)
Number recruited 449 (204, 915) 368 (225, 872)
Time recruiting (days) 1162 (730, 1472) 912 (649, 1272
632 J.A. Cook et al. / Contemporary Clinical Trials 29 (2008) 631–634including where viable, a surgical placebo. In general, surgical
trials can be considered to fall into three levels of increasing
difﬁculty to conduct:
• Level 1 — randomised comparisons of surgical procedures
which differ only in a minor way (e.g. a comparison of two
methods of suturing) [7]
• Level 2 — randomised comparisons of different forms of
surgerywhichdiffer in a signiﬁcantway in termsof the overall
approachandskills required (e.g. a comparisonof laparoscopic
surgery versus open surgery for inguinal hernia) [8]
• Level 3— randomised comparisons of some form of medical
management versus a surgical intervention (e.g. proton
pump inhibitors versus fundoplication for gastro-oesopha-
geal reﬂux disease) [9].
Issues of patient preference and clinical equipoise are
likely to be greatest where the difference between compar-
isons is greatest [10].
While there is anecdotal speculation to support the
inference that recruitment to surgical trials is more challen-
ging than for medical trials, we are unaware of any formal
assessment of this. The aim of this work was to use empirical
data to assess whether there is evidence that recruitment to
surgical trials is more difﬁcult than for medical trials. Two
aspects were considered, overall recruitment to the trial (trial
level) through the assessment of a cohort of trials, and
recruitment at the centre level through three example
surgical trials.
2. Methods
We assessed recruitment to surgical trials in general by
testing two pre-speciﬁed hypotheses on data from a cohort of
publicly funded trials. We ﬁrstly hypothesised that surgical
trials would be more difﬁcult to recruit to and therefore they
have a higher level of recruitment activity than medical trials
(Hypothesis A) and secondly that the surgical trials of greater
complexity (as deﬁned earlier) would similarly lead to a
higher level of recruitment activity (Hypothesis B).
To test Hypotheses A and B, we used a simple measure of
recruitment activity for multicentre randomised controlled
trials, the Recruitment Index [11], which is deﬁned as the
average number of days taken to recruit a participant in a
centre:
RI ¼ RecruitmentPeriod No:centres
No:participants
:
For example, a trial which recruited 100 patients in
200 days over 5 centres would have a RI of 10 (averageTable 2
Example surgical trials summary information
Surgical trial level Clinical area No. of
centres
Actual (target)
recruitment
RI
1 Orthopaedics 27 1715 (1500) 20.4
2 General Surgery 26 1027 (1000) 30.9
3 Gastroenterology 20 357 (600) 67.6number of centre recruitment days per recruit). We calculated
the RI for a cohort of publicly funded trials to measure the
level of recruit activity for surgical trials. The RI was calculated
on the basis of the actual number recruited as opposed to the
number completing the trial protocol which was not
consistently recorded. We tested for an overall difference
between surgical and medical trials to assess Hypothesis A.
Level 3 trials versus the remaining trials was tested to assess
Hypothesis B.
For hypothesis generating purposes, and to illustrate
complexities of multicentre recruitment within surgical)trials, two hypotheses were tested on three example surgical
trials. First, we hypothesised that late starting centres would
recruit less than early starting centres (Hypothesis C).
Second, we hypothesised that the rate of recruitment within
centres would reduce during the course of the trial
(Hypothesis D).
All hypotheses were tested using a Mann–Whitney U test
at the 5% signiﬁcant level in SPSS [12]. The Recruitment Index,
the number recruited and the rate of recruitment were
summarised as median and interquartile range (IQR). A 95%
conﬁdence interval for the median difference was calculated
in STATA [13].
3. Data
3.1. Cohort
The STEPS project carried out a review of publicly funded
trials from two UK funding bodies, the UK NHS R&D National
Methodology Programme and the UK Medical Research
Council (MRC) [2]. All multicentre trials except for cluster
randomised trials were included. Data was collected on the
114 multicentre trials, which recruited between 1994 and
2002, on recruitment and ﬁnance details from application
forms and progress reports. Where insufﬁcient data was
available in the STEPS database a search for trial publications
was undertaken to collect additional details which may not
have been available when the original search was conducted.
For individual trials recruited to more than one randomised
comparison, only the comparison with the largest target
recruitment was considered. Though UK funded, 25 (22%) of
the trials also had centres based outside the UK. A pilot study
had been undertaken for 60 of the Trials (53%). Two reviewers
independently categorised the cohort as either a surgical or
medical trial (Table 1). Any differences were resolved by
consensus.
3.2. Example trials
Centre level recruitment data was available for three
surgical trials, one representing each of the three levels of
surgical trials. Basic information on the three surgical trials
Table 3
Number of participants recruited in early and late starting centres for 3
example surgical trials
Example
trial
Number of participants recruited per month —
median (IQR)
p
value
Early centres Late centres
n Median (IQR) n Median (IQR)
1 13 4.1 (2.6, 5.0) 14 1.8 (1.4, 4.8) 0.077
2 13 1.9 (1.0, 2.7) 13 1.0 (0.7, 1.7) 0.065
3 10 0.8 (0.5, 1.2) 10 0.9 (0.8, 1.9) 0.369
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trials differed in size and clinical area.
4. Results
4.1. Cohort
The cohort included trials from a variety of clinical areas
(including Cancer, HIV/AID, urology, primary care and mental
health) and setting (hospital, community and general prac-
tice). Trial varied greatly in their target recruitment between
60 and 66,000. The number of centres, number of participants
recruited and the time recruiting (start of recruitment to end
of recruitment) are given in Table 1 for surgical and medical
trials.
The Recruitment Index was found to be higher, though not
statistically signiﬁcantly, in the surgical group (n=18, med-
ian=38.0 IQR (10.7, 77.4)) versus (n=81, median=34.8 IQR
(11.7, 98.0)) days per recruit for the medical group (median
difference 1.7 (−19.2, 25.1); p=0.828). For trials which
compared a surgical against a medical comparison (level 3),
the Recruitment Index was substantially higher (n=6, 68.3
(23.5, 294.8)) versus (n=93, 34.6 (11.7, 90.0); median
difference 25.9 (−35.5, 221.8); p=0.291) for the other trials.
4.2. Example trials
The results for Hypotheses C and D are given in Tables 3
and 4 respectively. Two of the three trials supported
Hypothesis C that latter centres do not recruit as well as
early centres. The median rate of recruitment for latter
centres was approximately a half that of the early centres
for trials 1 and 2.
All 3 tended towards a reduction in the rate of recruitment
within centre (Hypothesis D) with one signiﬁcant at the 5%
level and one just failing to be so. Substantial reductions in
the number of participants recruited were observed betweenTable 4
Number of participant recruited within centres for 3 example surgical trials
Example
trial
Number of participants recruited — median (IQR) p
value
1st half of recruitment
period
2nd half of recruitment
period
1 30 (11, 44) 21 (6, 45) 0.052
2 8 (4, 19) 6 (2, 23) 0.122
3 10 (6, 14) 5 (1, 11) 0.022the ﬁrst half of centre's recruitment period and the second
half.
5. Discussion
In general, there was no clear evidence that surgical trials
differ from medical trials in terms of recruitment activity.
There was, however, support for the inference that complex
(level 3) surgical trials are more difﬁcult to recruit to. We
suggest that the 3 levels of surgical trials is a useful paradigm
for understanding the variation in required recruitment
activity between surgical trials.
The Recruitment Index is a simple measure of the
recruitment rate for a multicentre trial. We found that the
index varied greatly between trials and it might be the case
that a more nuanced measure may be more sensitive to
differences between trials. For example, extending the
measure to the centre level might provide a more accurate
picture of recruitment as centres may have staggered start
dates.
The exploratory centre level analysis illustrated that
recruitment is a complex process within a trial and empha-
sised the variation in recruitment both between and within
centres. Haidich and Ioannidis [14] previously demonstrated a
difference between late starting centres and early centres for
AIDS trials and we found a broadly consistent pattern. There
was also some evidence of slowing down in recruitment
during the trial period.
Patient preference is often the most notable reason for
recruitment being difﬁcult to surgical trials [15]. Surgical
treatment polarises participant attitudes for and against
surgery. Further research is needed to investigate whether
other factors also play a part and to what degree recruitment
strategies can improve participation rates for these trials.
There were a number of limitations to our study. To enable
calculation of the Recruitment Index we used the number of
participant randomised. This ignored the quality of data on
those included in the trial. The need for long-term follow up
to evaluate surgical interventions has been highlighted and
consideration of retainment of participant was not assessed
[5]. Though we looked at a large cohort of trials there was a
relatively small number of surgical trials available. Similarly,
we only considered three surgical trials at the centre level and
therefore cautious interpretation is needed. It is uncertain
whether our results would hold for commercial as opposed to
publicly funded trials and investigation of this is warranted.
5.1. Conclusions
We found no clear evidence to support the assertion that
recruitment to surgical trials in general is more difﬁcult than
other clinical areas. However, complex (medical versus surgical)
trials appear substantially more difﬁcult to recruit to. Formal
exploration of the recruitment data through a modelling
approach may go some way to tease out where important
differences exist and could inform future trial design.
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